Novavax Exec Says List Price For Its Covid Vaccine Is $130 Per Dose
Portfolio Pulse from Benzinga Newsdesk
An executive from Novavax has stated that the list price for its Covid-19 vaccine is $130 per dose.
September 12, 2023 | 5:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novavax's Covid-19 vaccine has a list price of $130 per dose, which could impact the company's revenues and stock price.
The announcement of the list price for Novavax's Covid-19 vaccine directly impacts the company's potential revenues from vaccine sales. This could lead to increased investor interest and a potential rise in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100